Diane Parks
Director/Board Member bei CALLIDITAS THERAPEUTICS AB
Vermögen: 109 110 $ am 31.03.2024
Profil
Diane L.
Parks is currently serving as an Independent Director at Soligenix, Inc., CTI BioPharma Corp., Kura Oncology, Inc., Calliditas Therapeutics AB, Lymphoma Research Foundation, TriSalus Operating Life Sciences, Inc., and Celularity, Inc. In the past, Ms. Parks worked as a Director at Healogix LLC from 2018 to 2019, Vice President-Sales at Amgen, Inc. from 2007 to 2014, Senior VP-Specialty Biotherapeutics & Managed Care at Genentech, Inc. from 1999 to 2005, Vice President & Head-Global Marketing at Pharmacyclics LLC from 2014 to 2015, and Senior VP-Marketing, Sales & Market Research at Kite Pharma, Inc. from 2016 to 2018.
Ms. Parks holds an MBA from Georgia State University and an undergraduate degree from Kansas State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.02.2023 | 8 449 ( 0,01% ) | 89 606 $ | 31.03.2024 | |
CELULARITY INC. CLASS A
0,02% | 13.03.2024 | 3 615 ( 0,02% ) | 18 906 $ | 31.03.2024 |
SOLIGENIX, INC.
0,01% | 08.03.2024 | 996 ( 0,01% ) | 598 $ | 31.03.2024 |
KURA ONCOLOGY, INC.
-.--% | 31.05.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Diane Parks
| Unternehmen | Position | Beginn |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Director/Board Member | 08.05.2019 |
| SOLIGENIX, INC. | Director/Board Member | 08.07.2019 |
| KURA ONCOLOGY, INC. | Director/Board Member | 14.10.2019 |
| CTI BIOPHARMA CORP. | Director/Board Member | 24.08.2021 |
| CELULARITY INC. | Director/Board Member | 03.06.2022 |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Director/Board Member | 24.07.2019 |
| Lymphoma Research Foundation | Director/Board Member | 01.09.2020 |
Ehemalige bekannte Positionen von Diane Parks
| Unternehmen | Position | Ende |
|---|---|---|
Healogix LLC
 Healogix LLC Miscellaneous Commercial ServicesCommercial Services Healogix LLC is a healthcare marketing research and consulting firm. The private company is based in Horsham, PA. The company was founded by Harris Kaplan. Harris Kaplan has been the CEO since incorporation. | Director/Board Member | 01.11.2019 |
| KITE PHARMA INC | Sales & Marketing | 01.07.2018 |
| ░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Diane Parks
| Georgia State University | Masters Business Admin |
| Kansas State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| SOLIGENIX, INC. | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| CELULARITY INC. | Commercial Services |
| Private Unternehmen | 7 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
| Lymphoma Research Foundation | |
Healogix LLC
Healogix LLC Miscellaneous Commercial ServicesCommercial Services Healogix LLC is a healthcare marketing research and consulting firm. The private company is based in Horsham, PA. The company was founded by Harris Kaplan. Harris Kaplan has been the CEO since incorporation. | Commercial Services |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
